<DOC>
<DOCNO>
EP-0001618
</DOCNO>
<TEXT>
<DATE>
19790502
</DATE>
<IPC-CLASSIFICATIONS>
A23K-1/16 A61K-31/55 A61P-31/00 C07D-241/52 C07D-403/00 A61K-31/495 A61K-20060101S C07D-20060101S C07D-241/00 C07D-403/06 A61P-31/04 A23K-1/17 A61K-31/53 
</IPC-CLASSIFICATIONS>
<TITLE>
process for the preparation of di-n-oxides and their pharmaceutical use
</TITLE>
<APPLICANT>
bayer agde<sep>bayer aktiengesellschaft<sep>bayer ag51368 leverkusende<sep>
</APPLICANT>
<INVENTOR>
metzger karl georg drde<sep>seng florin drde<sep>metzger, karl georg, dr.<sep>seng, florin, dr.<sep>metzger, karl georg, dr.pahlkestrasse 15d-5600 wuppertal 1de<sep>seng, florin, dr.am katterbach 46d-5060 bergisch-gladbach 2de<sep>
</INVENTOR>
<ABSTRACT>
the preparation of quinoxaline di-n-oxides with antibacterial activity and the use thereof as pharmaceuticals, especially as antibacterial agents and as feed additives, are described.  the quinoxaline di-n-oxides have potent antibacterial properties and are administered to humans or animals suffering from bacterial diseases. 
</ABSTRACT>
</TEXT>
</DOC>
